Final ID:
Alexander Kevin, Witteles Ronald
Primary results from the phase 2 randomized, placebo controlled, blinded trial of the monoclonal antibody coramitug in transthyretin amyloid cardiomyopathy (ATTR-CM)Fontana Marianna, Kar Soumitra, Revanna Manjunatha, Sarswat Nitasha, Tsujita Kenichi, Maurer Mathew, Garcia-pavia Pablo, Grogan Martha, Shah Sanjiv, Engelmann Mads, Hovingh G. Kees, Kristen Arnt, Lim-watson Michelle, Malling Brian